WQ Qiu, R Pan, Y Tang, XG Zhou, JM Wu, L Yu… - Biomedicine & …, 2020 - Elsevier
Emerging evidence indicates that the enhancement of microglial autophagy inhibits the NLRP3 inflammasome mediated neuroinflammation in Alzheimer's disease (AD) …
Y Zhang, Y Zhao, J Zhang, Y Gao, S Li, C Chang… - Neuroscience …, 2021 - Elsevier
Nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome-mediated chronic neuroinflammation plays a crucial role in the progression …
L Feng, L Zhang - DNA and Cell Biology, 2019 - liebertpub.com
Microglia-mediated neuroinflammation plays an important role in Alzheimer's disease development. Resveratrol, a natural polyphenol from the Japanese knotweed (Polygonum …
HM Wang, T Zhang, JK Huang, JY Xiang… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: Microglial activation is an important pathological feature in the brains of patients with Alzheimer's disease (AD), and amyloid-β (Aβ) peptides play a crucial role in …
A Naeem, R Prakash, N Kumari, MA Khan… - Brain, Behavior, and …, 2024 - Elsevier
Alzheimer's disease (AD) is the seventh most common cause of mortality and one of the major causes of disability and vulnerability in the elderly. AD is characterized by gradual …
JM Li, T Hu, XN Zhou, T Zhang, JH Guo… - Journal of …, 2023 - Springer
Background Numerous studies have found that inhibiting the expression of NLRP3 inflammasome can significantly improve depressive-like behaviors in mice, but the research …
W Cui, C Sun, Y Ma, S Wang, X Wang… - Frontiers in …, 2020 - frontiersin.org
Accumulating evidence has indicated that activation of microglia and neuroinflammation reaction play a prominent role in Alzheimer's disease (AD). Inhibition of toll-like receptor 4 …
J Lo, CC Liu, YS Li, PY Lee, PL Liu, PC Wu… - Journal of …, 2022 - Taylor & Francis
Purpose Neurodegenerative diseases are associated with neuroinflammation along with activation of microglia and oxidative stress, but currently lack effective treatments …
L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - Springer
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack of effective therapeutic drugs for this disease. We investigated the potential therapeutic …